Avania names MedTech industry ace Todd M. Pope new Board Chairman

Todd M. Pope, Board Chairman at Avania

Avania, a global medical technology contract research organization (CRO), has appointed Todd M. Pope as the new Chairman of the Board of Directors. Todd brings 30 years of technology, medical device, and leadership experience across large cap and startup MedTech and was named to TIME Magazine’s 2018 list of 50 Most Influential People in Healthcare.

What does Todd bring to Avania in the role?

Having spent the last 20 years in CEO roles in both private and public firms, he also serves as the chairman of the board of directors of AdvaMed ACCEL, the division within AdvaMed dedicated to addressing the unique needs of small and startup medical tech manufacturers.

Commenting on his new role, Pope, said, “I am very pleased to take on this role at such a dynamic time and support Avania on its growth journey. After a rewarding career leading companies in the MedTech industry, I am motivated by the opportunity to work alongside the senior management team to execute on Avania’s transformational business strategy.”

Todd’s past roles included Global President of Johnson & Johnson Cordis, President and CEO of TransEnterix, and other senior executive roles within the MedTech space. Todd is Director of the boards of Distalmotion and Humacyte, and a Partner at Revival Healthcare Capital.

What does the appointment mean for Avania?

Sapna Hornyak, President and Chief Executive Officer at Avania

“Todd’s long history of leadership and his deep commercial experience in the MedTech space makes him an ideal person for this role,” said Sapna Hornyak, President and CEO of Avania.

“I look forward to working closely with Todd to ensure Avania continues to make a positive impact for all stakeholders, including Avania’s customers, our people, and the MedTech space. The senior management team along with the board of directors are excited about the future and look forward to bringing Avania to the next new phase with our new chairman.”

“We are excited to work with Todd. He brings a wealth of MedTech expertise and relationships that will provide invaluable connections with clients and insights into their evolving needs, and how Avania can best serve them. Todd’s leadership experience, with small and large businesses, will also support Avania as it grows and scales,” added Edouard Pillot, Managing Partner, and Enrico Grasso, Partner of Astorg Mid-Cap, which has majority interest in Avania.